Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09AHN
|
||||
| Former ID |
DNC005905
|
||||
| Drug Name |
N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H23N3O3
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NCC#N)NC(=O)OC(C)(C)C
|
||||
| InChI |
1S/C13H23N3O3/c1-9(2)8-10(11(17)15-7-6-14)16-12(18)19-13(3,4)5/h9-10H,7-8H2,1-5H3,(H,15,17)(H,16,18)/t10-/m0/s1
|
||||
| InChIKey |
OMQSGXGRANQGLE-JTQLQIEISA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [527885] | |
| Cathepsin S | Target Info | Inhibitor | [527885] | ||
| Cathepsin K | Target Info | Inhibitor | [527885] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.